6-(4-羟基苯基)己酸甲酯 | 113379-10-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 酚类
• 中文名称: 6-(4-羟基苯基)己酸甲酯
• 英文名称: methyl 6-(4-hydroxyphenyl)hexanoate
• CAS: 113379-10-5
• 化学式: C₁₃H₁₈O₃
• 分子量: 222.284
• InChiKey: UBEHKVPLADHAQM-UHFFFAOYSA-N

物化性质

• 沸点：
  345.0±25.0 °C(Predicted)
• 密度：
  1.075±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  16
• 可旋转键数：
  7
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.46
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  6-(4-羟基苯基)己酸甲酯 在 sodium hydroxide 作用下， 以 甲醇 为溶剂， 以100%的产率得到6-(4-羟苯基)己酸
  参考文献：
  名称：

  Initial structure–activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindoles

  摘要：

  A nonpeptidyl GnRH receptor antagonist (1), with a unique 2-arylindole core, was identified through the Merck inhouse screening for binding affinity on the rat GnRH receptor. SAR studies directed toward the alkoxy-ethanolamine and 2-aryl groups resulted in a simpler lead structure with improved activity. This compound 50 exhibits a 60-fold improvement in binding activity over our initial lead 1. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00707-1
• 作为产物：
  描述：

  4-(4-(苄氧基)苯基)丁酸 在 palladium dihydroxide 氢气 、 二甲羟胺盐酸盐 、 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 甲醇 、 二氯甲烷 、 乙酸乙酯 为溶剂， 生成 6-(4-羟基苯基)己酸甲酯
  参考文献：
  名称：

  Initial structure–activity relationship of a novel class of nonpeptidyl GnRH receptor antagonists: 2-arylindoles

  摘要：

  A nonpeptidyl GnRH receptor antagonist (1), with a unique 2-arylindole core, was identified through the Merck inhouse screening for binding affinity on the rat GnRH receptor. SAR studies directed toward the alkoxy-ethanolamine and 2-aryl groups resulted in a simpler lead structure with improved activity. This compound 50 exhibits a 60-fold improvement in binding activity over our initial lead 1. (C) 2001 Elsevier Science Ltd. All rights reserved.

  DOI：

  10.1016/s0960-894x(00)00707-1

文献信息

• [EN] METAL CHELATE COMPOUNDS FOR BINDING TO THE PLATELET SPECIFIC GLYCOPROTEIN IIB/IIIA<br/>[FR] CHÉLATES MÉTALLIQUES POUR LA LIAISON À LA GLYCOPROTÉINE IIB/IIIA SPÉCIFIQUE DES PLAQUETTES
  申请人：BAYER PHARMA AG

  公开号：WO2014124943A1

  公开（公告）日：2014-08-21

  The present invention is directed to compounds that bind to glycoprotein IIb/IIIa and can be used for diagnostic imaging, in particular magnetic resonance imaging of thrombi. The disclosed compounds enable the binding to glycoprotein IIb/IIIa receptor combined with an adequate relaxivity.

  本发明涉及结合到糖蛋白IIb/IIIa的化合物，可用于诊断成像，特别是磁共振成像血栓。所公开的化合物使得结合到糖蛋白IIb/IIIa受体并具有适当的弛豫率成为可能。
• PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONISTS
  申请人：Cano Ivan Collado

  公开号：US20090062358A1

  公开（公告）日：2009-03-05

  The present invention is directed to compounds represented by the following structural formula, and pharmaceutically acceptable salts, solvates and hydrates thereof, R1 is a substituted or unsubstituted group selected from C 1 -C 8 alkyl, aryl-C 0-2 -alkyl, heteroaryl-C 0-2 -alkyl, C3-C6 cycloalkylaryl-C 0-2 -alkyl or phenyl. W is O or S. R2 is H or a substituted or unsubstituted group selected from C 1 -C 6 alkyl, C 3 -C 6 cycloalkyl and heteroaryl. X is a C 2 -C 5 alkylene linker wherein one carbon atom of the linker may be replaced with O, NH or S. Y is C, O, S, NH or a single bond. Furthermore, E is (CH 2 ) n COOH, wherein n is 0, 1, 2 or 3, or C(R3)(R4)A, wherein A is an acidic functional group such as carboxyl, carboxamide substituted or unsubstituted sulfonamide, or substituted or unsubstituted tetrazole. R3 is H, saturated or unsaturated C 1 -C 5 alkyl, C 1 -C 5 alkoxy. Additionally, R4 is H, halo, a substituted or unsubstituted group selected from C 1 -C 5 alkyl, C 1 -C 5 alkoxy, C 3 -C 6 cycloalkyl, arylC 0 -C 4 alkyl and phenyl, or R3 and R4 are combined to form a C 3 -C 4 cycloalkyl.

  本发明涉及以下结构式所代表的化合物，以及其药学上可接受的盐、溶剂合物和水合物，其中，R1是C1-C8烷基、芳基-C0-2-烷基、杂芳基-C0-2-烷基、C3-C6环烷基芳基-C0-2-烷基或苯基的取代或未取代基团。W为O或S。R2为H或C1-C6烷基、C3-C6环烷基和杂芳基的取代或未取代基团。X为C2-C5烷基链，在链中的一个碳原子可以被O、NH或S取代。Y为C、O、S、NH或单键。此外，E为(CH2)nCOOH，其中n为0、1、2或3，或C(R3)(R4)A，其中A为酸性功能基团，如羧基、羧酰基取代或未取代的磺酰胺基、取代或未取代的四唑基。R3为H、饱和或不饱和的C1-C5烷基、C1-C5烷氧基。此外，R4为H、卤素、C1-C5烷基、C1-C5烷氧基、C3-C6环烷基、芳基C0-C4烷基和苯基的取代或未取代基团，或R3和R4结合形成C3-C4环烷基。
• METAL CHELATE COMPOUNDS FOR BINDING TO THE PLATELET SPECIFIC GLYCOPROTEIN IIB/IIIA
  申请人：BAYER PHARMA AKTIENGESELLSCHAFT

  公开号：US20160008490A1

  公开（公告）日：2016-01-14

  The present invention is directed to compounds that bind to glycoprotein IIb/IIIa and can be used for diagnostic imaging, in particular magnetic resonance imaging of thrombi. The disclosed compounds enable the binding to glycoprotein IIb/IIIa receptor combined with an adequate relaxivity.

  本发明涉及一种与糖蛋白IIb/IIIa结合的化合物，可用于诊断成像，特别是血栓的磁共振成像。所披露的化合物使得与糖蛋白IIb/IIIa受体的结合与适当的松弛度相结合。
• Intramolecular radical cyclization of phenolic enolates
  作者：Andrew S. Kende、Kevin. Koch、Cynthia A. Smith

  DOI：10.1021/ja00215a034

  日期：1988.3
• Discovery and structure-guided optimization of tert-butyl 6-(phenoxymethyl)-3-(trifluoromethyl)benzoates as liver X receptor agonists
  作者：Yumi Matsui、Takahiro Yamaguchi、Takanori Yamazaki、Masayuki Yoshida、Masami Arai、Naoki Terasaka、Shoko Honzumi、Kenji Wakabayashi、Shinko Hayashi、Daisuke Nakai、Hiroyuki Hanzawa、Kazuhiko Tamaki

  DOI：10.1016/j.bmcl.2015.07.047

  日期：2015.9

  To obtain potent liver X receptor (LXR) agonists, a structure-activity relationship study was performed on a series of tert-butyl benzoate analogs. As the crystal structure analysis suggested applicable interactions between the LXR ligand-binding domain and the ligands, two key functional groups were introduced. The introduction of the hydroxyl group on the C6-position of the benzoate part enhanced the agonistic activity in a cell-based assay, and the carboxyl group in terminal improved the pharmacokinetic profile in mice, respectively. The obtained compound 32b increased blood ABCA1 mRNA expression without plasma TG elevation in both mice and cynomolgus monkeys. (C) 2015 Elsevier Ltd. All rights reserved.